Watchlist Price Alert

Becton Dickinson and (BDX)

NYSE: BDX · Real-Time Price · USD

168.32

-1.22 (-0.72%)

At close: May 02, 2025, 3:59 PM

168.60

0.17%

After-hours: May 02, 2025, 05:44 PM EDT

-0.72% (1D)

Bid	168.2
Market Cap	48.33B
Revenue (ttm)	20.87B
Net Income (ttm)	1.5B
EPS (ttm)	5.15
PE Ratio (ttm)	32.68
Forward PE	10.83
Analyst	Buy

Ask	170
Volume	9,697,017
Avg. Volume (20D)	2,387,032
Open	171.26
Previous Close	169.54
Day's Range	166.12 - 171.26
52-Week Range	166.12 - 251.99
Beta	0.38

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and pr...

Sector Healthcare

IPO Date Feb 21, 1973

Employees 70,000

Stock Exchange NYSE

Ticker Symbol BDX

Website https://www.bd.com

Full Company Profile

Analyst Forecast

According to 8 analyst ratings, the average rating for BDX stock is "Buy." The 12-month stock price forecast is $272, which is an increase of 61.60% from the latest price.

Stock Forecasts

Earnings Surprise

Becton Dickinson and has released their quartely earnings on May 1, 2025:

Revenue of $5.27B misses estimates by $78M, with 4.50% YoY growth.

EPS of 3.35 exceeds estimates by 0.07, with 5.68% YoY growth.

Why Price Moved

2 days ago

Becton, Dickinson and Company shares are trading l... Unlock content with Pro Subscription

3 days ago

-18.13%

Becton Dickinson shares are trading lower after the company cut FY25 EPS guidance despite a sales outlook guidance raise. The company also missed Q2 revenue estimates.

News

2 days ago · benzinga.com

Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years

Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.

2 days ago · seekingalpha.com

9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next

I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-vo...

3 days ago · marketwatch.com

Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales

Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research...

3 days ago · https://thefly.com

William Blair downgrades Becton Dickinson on 'disappointing' Q2 update

01 May

3 days ago · seekingalpha.com

Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript

Becton, Dickinson and Company (NYSE:BDX ) Q2 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom...

2 days ago · zacks.com

Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall...

2 days ago · youtube.com

Cramer's Stop Trading: Becton Dickinson

CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson.

3 days ago · zacks.com

Becton Dickinson (BDX) Q2 Earnings Top Estimates

Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago.

3 days ago · reuters.com

Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit

Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in prema...

4 days ago · zacks.com

MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK

This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.

Load More News